Market Overview

Vaccines Market to reach value of around US$ 48.0 Bn by 2025, Says TMR

Share:

Albany, New York, July 26, 2018 (GLOBE NEWSWIRE) -- The global vaccines market was valued at US$28.0 bn in 2016 and is expected to exhibit a CAGR of more than 6.0% over the forecast period from 2017 to 2025 to attain value of around US$48.0 bn by the end of 2025.  On the basis of route of vaccination, the market is dominated by the injectable vaccines owing to high adoption of injectable vaccines for its convenience, effectiveness, and ease. North America is anticipated to dominate the global market for vaccines thanks to continuous funding for research activities and vaccine development in the region. However, Asia Pacific is projected to record a faster growth with higher rate over the forecast period, owing to increasing prevalence of diseases such as tuberculosis, malaria, and dengue in the region.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21

Rising Government Initiatives to Drive Growth

Vaccines offer immunity against a particular disease. Vaccines contain a resembling agent, which stimulates the immunity system to distinguish the foreign object and to destroy them. Better efficiency and functionality of these vaccines are boosting their adoption for treatment of various diseases, which is likely to boost the global market for vaccines. Additionally, rising incidences of infectious diseases such as influenza, pneumonia, malaria, meningococcal meningitis, hepatitis, measles, HIV, dengue, and diphtheria are increasing globally. This is major factor boosting need for the proper vaccinations to treat the diseases which in turn driving growth of the global vaccines market.

Request PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21

Rising government initiatives favoring vaccination drives worldwide is bolstering growth of the vaccines market. In addition to this, key players are focus on adopting new technologies for vaccine delivery, which are easy, quick, and safe substitutes for the conventional methods. This strategy has immense potential to increase patient acceptability and also increase the rates of immunization  

Continuous Funding for Research Activities to Drive the Global Market

However, high cost experienced in vaccine development and production is key factor hampering growth of the global market for vaccines. In addition, presence of stringent regulations and policies for the practice of vaccine is expected to hamper the market in the years to come.

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=21

Nevertheless, the increase in investment from key players and local governments, as well, to improve and increase research and development activities in the field of vaccines is creating opportunities for growth of vaccines market, significantly.

The global vaccines market as per a report by Transparency Market Research (TMR) exhibits a highly competitive environment owing to presence of several players. In order to gain edge over rivals, several leading companies are investing in research and development initiatives. Furthermore, many companies are focusing on product launches, which could intensify the competition further in the coming years.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=21

Some of the major players in the global vaccines market are Sanofi Pasteur SA, GlaxoSmithKline plc. Pfizer, Inc., Serum Institute of India Ltd, Merck & Co., Inc., Emergent BioSolutions Inc., Janssen Pharmaceutical Company, CSL Ltd, Mitsubishi Tanabe Pharma Corporation, and Novavax AB.

The information is comprised in the new report of TMR, titled "Vaccines Market (Vaccine Type - Inactivated, Live Attenuated, Toxoid, Conjugate; Valance - Monovalent, Multivalent; Route of Administration - Oral, Injectable; Indication - Influenza, Hepatitis, Polio, Meningococcal Disease, Pneumococcal Disease, DTP, Rotavirus, MMR, Human Papilloma Virus; Distribution Channel - Institutional Sales, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025."

More Trending Reports by Transparency Market Research -

Veterinary Vaccines Market: https://www.transparencymarketresearch.com/veterinary-vaccines-market.html

Porcine Vaccines Market: https://www.transparencymarketresearch.com/porcine-vaccines-market.html

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact
Mr. Nachiket Ghumare
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Research Blog: http://theglobalhealthnews.com/

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
XECImperial CapitalDowngrades35.0
SSTIImperial CapitalUpgrades49.0
AVDLoop CapitalUpgrades29.0
FCREYDeutsche BankUpgrades0.0
OECUBSUpgrades34.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.